Impact of Disease Stage, Treatment Timing, and Demographic Disparities on Survival in Vulvar Squamous Cell Carcinoma: Insights from a SEER-Based Analysis

Melanoma and Skin Cancer

Sunburn and Cutaneous Squamous Cell Carcinoma: A Meta-Analysis

JAMA Dermatol

Weber I, Liao K, Dang T, Shah M, Wehner MR

doi: 10.1001/jamadermatol.2025.3473

Melanoma and Skin Cancer

Risk Factor Number and Recurrence, Metastasis, and Disease-Related Death in Cutaneous Squamous Cell Carcinoma

JAMA Dermatol

Ran NA, Granger EE, Brodland DG, Cañueto J, Carr DR, Carter JB, Carucci JA, Hirotsu KE, Koyfman SA, Mangold AR, Girardi FM, Shahwan KT, Srivastava D, Vidimos AT, Willenbrink TJ, Wysong A, Ruiz ES

doi: 10.1001/jamadermatol.2025.0128

Melanoma and Skin Cancer

Lymphovascular invasion is an independent predictor of metastasis and disease-specific death in cutaneous squamous cell carcinoma: a multicenter retrospective study

J Am Acad Dermatol

Hirotsu KE, Aasi SZ, Samson KK, Zheng C, Nazaroff JR, Voller LM, Ruiz ES, Ran NA, Granger EE, Koyfman SA, Vidimos AT, Carr DR, Shahwan KT, Carucci JA, Carter JB, Cañueto J, Girardi FM, Mangold AR, Srivastava D, Brodland DG, Zitelli JA, Willenbrink TJ, Wysong A

doi: 10.1016/j.jaad.2025.04.029

Melanoma and Skin Cancer

Disparities in Survival and Tumor Characteristics in Patients With Single and Multiple Primary Merkel Cell Carcinomas

J Am Acad Dermatol

Luo Z, Sun Y, Guo Z, Le J, Zhang S, Yu Y, Xu S, Zeng F, Deng G

doi: 10.1016/j.jaad.2025.08.052

Melanoma and Skin Cancer

Development of Gene-Expression Panel Predictive of Local Recurrence, Metastasis, and Overall Survival in Intermediate to High-risk Cutaneous Squamous Cell Carcinoma: A Cohort Study

J Am Acad Dermatol

Leibovit-Reiben Z, Stockard A, Nassir S, Yousif M, Li X, Severson KJ, Hughes A, Kechter J, Hwang A, Boudreaux B, Bhullar P, Zhang N, Butterfield RJ, Ma T, Cardona-Machado CD, Pérez-Baena MJ, Costello CM, Nelson SA, DiCaudo DJ, Baum CL, Pittelkow MR, Cañueto J, Mangold AR

doi: 10.1016/j.jaad.2025.10.136

Melanoma and Skin Cancer

Avelumab plus cetuximab in patients with unresectable stage III or IV cutaneous squamous cell carcinoma - clinical activity and safety results from AliCe, a single-arm, multicentre phase 2 DeCOG trial

Br J Dermatol

Becker JC, Gesierich AH, Leiter U, Zimmer L, Hassel JC, von Wasielewski I, Ziemer M, Fluck M, Meier F, Spillner AN, Schilling B, Eigentler TK, Livingstone E, Ugurel S, Angela Y, Windemuth-Kieselbach C, Gutzmer R

doi: 10.1093/bjd/ljaf303

Melanoma and Skin Cancer

Atezolizumab in High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial

JAMA

Haddad R, Fayette J, Teixeira M, Prabhash K, Mesia R, Kawecki A, Dechaphunkul A, Dinis J, Guo Y, Masuda M, Hsieh CY, Ghi MG, Vaz de Melo Sette C, Harrington K, Tahara M, Saba NF, Lau A, Jiang T, Yan Y, Ballinger M, Kaul M, Matheny C, Cuchelkar V, Wong DJ

doi: 10.1001/jama.2025.1483

Melanoma and Skin Cancer

Retifanlimab with carboplatin and paclitaxel for locally recurrent or metastatic squamous cell carcinoma of the anal canal (POD1UM-303/InterAACT-2): a global, phase 3 randomised controlled trial

Lancet

Rao S, Samalin-Scalzi E, Evesque L, Ben Abdelghani M, Morano F, Roy A, Dahan L, Tamberi S, Dhadda AS, Saunders MP, Casanova N, Guimbaud R, Lievre A, Maurel J, Fakih M, Tian C, Harrison J, Jones MM, Cornfeld M, Spano JP, Rochefort P, POD1UM-303/InterAACT-2 study investigators

doi: 10.1016/S0140-6736(25)00631-2

Melanoma and Skin CancerImmunotherapy

Improved survival at the population level for patients with advanced Merkel cell carcinoma following availability of immunotherapy

J Am Acad Dermatol

Paulson KG, Park SY, Bhatia S, Hippe DS, Nghiem P

doi: 10.1016/j.jaad.2025.03.006

Related content

Sunburn and Cutaneous Squamous Cell Carcinoma: A Meta-Analysis

Risk Factor Number and Recurrence, Metastasis, and Disease-Related Death in Cutaneous Squamous Cell Carcinoma

Lymphovascular invasion is an independent predictor of metastasis and disease-specific death in cutaneous squamous cell carcinoma: a multicenter retrospective study

Disparities in Survival and Tumor Characteristics in Patients With Single and Multiple Primary Merkel Cell Carcinomas

Development of Gene-Expression Panel Predictive of Local Recurrence, Metastasis, and Overall Survival in Intermediate to High-risk Cutaneous Squamous Cell Carcinoma: A Cohort Study

Avelumab plus cetuximab in patients with unresectable stage III or IV cutaneous squamous cell carcinoma - clinical activity and safety results from AliCe, a single-arm, multicentre phase 2 DeCOG trial

Atezolizumab in High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial

Retifanlimab with carboplatin and paclitaxel for locally recurrent or metastatic squamous cell carcinoma of the anal canal (POD1UM-303/InterAACT-2): a global, phase 3 randomised controlled trial

Improved survival at the population level for patients with advanced Merkel cell carcinoma following availability of immunotherapy